Brind.

Akebia Therapeutics is headquartered in Cambridge, Massachusetts.

7 reports, 1 independent Updated Jul 1
Gone quiet
Reports
7
Developments
1
Repetition
86%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Akebia Therapeutics is headquartered in Cambridge, Massachusetts.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireAkebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical
  • GlobeNewswireAkebia Therapeutics to Present at Canaccord Genuity’s 45th Annual Growth Conference CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical
  • GlobeNewswireAkebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical c
  • GlobeNewswireAkebia Therapeutics to Report Second Quarter 2025 Financial Results and Discuss Recent Business Highlights Akebia to Host Conference Call on August 7, 2025, at 8:00 a.m. EDT CAMBRIDGE, Mass., July 31
  • Unknown outlet
  • Unknown outlet
1 more outlet ran the same wire story